FAGR.BR • EURONEXT
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
With a PE ratio of 18.21 and EPS of €1.17, Fagron NV appears reasonably valued relative to typical healthcare/industrial peers, suggesting neither clear overvaluation nor deep value. The earnings profile implied by the EPS supports profitability, but without multi-year revenue, margin, and cash flow data, it is difficult to argue for a strongly bullish or bearish stance. Overall, the financial picture looks stable but not clearly compelling in either direction.
The stock has risen 2.9% over the last month and trades modestly above its 200-day moving average, indicating a mild upward bias but not a strong uptrend. An RSI of 45.46 sits in the middle of the range, suggesting neither overbought nor oversold conditions. Overall, price action and technicals point to a consolidating stock with a slight positive tilt but no strong momentum signal.
Web traffic is flat month over month at roughly 34,484 visitors, suggesting stable but not accelerating digital engagement. Job openings are up 29.5% month over month to 57, which can signal planned growth or investment, while social media metrics are largely flat with only minor changes. Collectively, alternative data hint at steady operations with some expansion intentions, but not a strong demand-driven growth surge.
Across fundamentals, technicals, and alternative data, Fagron NV presents as a stable, moderately valued company without strong near-term catalysts evident in the provided data. Profitability and a modestly positive price trend are balanced by flat web traffic and largely stagnant social media growth, resulting in a neutral overall stance. The stock may appeal to investors seeking steady exposure rather than aggressive growth or deep value opportunities.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
You don't hold FAGR.BR in your mock portfolio yet.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: